Skip to main content
PMC home page
The BMJ logoLink to The BMJ
. 1994 Jun 4;308(6942):1462–1467. doi: 10.1136/bmj.308.6942.1462

Active cascade testing for carriers of cystic fibrosis gene.

M Super 1, M J Schwarz 1, G Malone 1, T Roberts 1, A Haworth 1, G Dermody 1
PMCID: PMC2540318  PMID: 8019278

Abstract

OBJECTIVE--To examine the acceptability, practicability, efficiency, and application of active screening for carriers of the cystic fibrosis gene in the extended families of those in whom the disease is present (Cascade screening). DESIGN--Paediatricians and physicians provide details of their affected patients, pedigrees are drawn up, and relatives offered tests after initial contact by the affected nuclear families. Affected patients are genotyped in a laboratory with a special interest in the genetics of cystic fibrosis. SETTING--North Western health region. SUBJECTS--Relatives and partners of 607 people with cystic fibrosis. INTERVENTIONS--Genetic counselling by letter for people found to be carriers; formal genetic counselling and when indicated arrangements for prenatal diagnosis for couples discovered to be carriers. MAIN OUTCOME MEASURES--Number of carrier couples detected; action in pregnancy of detected carrier couples; extent of the uptake of screening by relatives. RESULTS--Of 1563 relatives or partners tested, 15 carrier couples were detected; of nine pregnancies undertaken by these 15, eight had prenatal tests and three terminated pregnancies. An average of 16 people per family have come forward for testing so far. CONCLUSIONS--Cascade screening for carriers of cystic fibrosis is well accepted by relatives, especially on the mother's side of the family; it is 10 times more efficient in detecting carrier couples than unfocused screening. Detected carrier couples make practical use of the information in pregnancy. Active cascade screening for carriers is effective in cystic fibrosis and widespread application is recommended. These principles could be applied to other recessive disorders.

Full text

PDF

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bekker H., Modell M., Denniss G., Silver A., Mathew C., Bobrow M., Marteau T. Uptake of cystic fibrosis testing in primary care: supply push or demand pull? BMJ. 1993 Jun 12;306(6892):1584–1586. doi: 10.1136/bmj.306.6892.1584. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Burn J. Screening for cystic fibrosis in primary care. BMJ. 1993 Jun 12;306(6892):1558–1559. doi: 10.1136/bmj.306.6892.1558. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Caskey C. T., Kaback M. M., Beaudet A. L. The American Society of Human Genetics statement on cystic fibrosis screening. Am J Hum Genet. 1990 Feb;46(2):393–393. [PMC free article] [PubMed] [Google Scholar]
  4. Ferrie R. M., Schwarz M. J., Robertson N. H., Vaudin S., Super M., Malone G., Little S. Development, multiplexing, and application of ARMS tests for common mutations in the CFTR gene. Am J Hum Genet. 1992 Aug;51(2):251–262. [PMC free article] [PubMed] [Google Scholar]
  5. Handyside A. H., Lesko J. G., Tarín J. J., Winston R. M., Hughes M. R. Birth of a normal girl after in vitro fertilization and preimplantation diagnostic testing for cystic fibrosis. N Engl J Med. 1992 Sep 24;327(13):905–909. doi: 10.1056/NEJM199209243271301. [DOI] [PubMed] [Google Scholar]
  6. Harris H., Scotcher D., Hartley N., Wallace A., Craufurd D., Harris R. Cystic fibrosis carrier testing in early pregnancy by general practitioners. BMJ. 1993 Jun 12;306(6892):1580–1583. doi: 10.1136/bmj.306.6892.1580. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Hubbard R. C., McElvaney N. G., Birrer P., Shak S., Robinson W. W., Jolley C., Wu M., Chernick M. S., Crystal R. G. A preliminary study of aerosolized recombinant human deoxyribonuclease I in the treatment of cystic fibrosis. N Engl J Med. 1992 Mar 19;326(12):812–815. doi: 10.1056/NEJM199203193261207. [DOI] [PubMed] [Google Scholar]
  8. Kerem B., Rommens J. M., Buchanan J. A., Markiewicz D., Cox T. K., Chakravarti A., Buchwald M., Tsui L. C. Identification of the cystic fibrosis gene: genetic analysis. Science. 1989 Sep 8;245(4922):1073–1080. doi: 10.1126/science.2570460. [DOI] [PubMed] [Google Scholar]
  9. Lench N., Stanier P., Williamson R. Simple non-invasive method to obtain DNA for gene analysis. Lancet. 1988 Jun 18;1(8599):1356–1358. doi: 10.1016/s0140-6736(88)92178-2. [DOI] [PubMed] [Google Scholar]
  10. Mennie M. E., Gilfillan A., Compton M., Curtis L., Liston W. A., Pullen I., Whyte D. A., Brock D. J. Prenatal screening for cystic fibrosis. Lancet. 1992 Jul 25;340(8813):214–216. doi: 10.1016/0140-6736(92)90476-j. [DOI] [PubMed] [Google Scholar]
  11. Modell M. Screening for carriers of cystic fibrosis--a general practitioner's perspective. BMJ. 1993 Oct 2;307(6908):849–852. doi: 10.1136/bmj.307.6908.849. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Morral N., Girbau E., Zielenski J., Nunes V., Casals T., Tsui L. C., Estivill X. Dinucleotide (CA/GT) repeat polymorphism in intron 17B of the cystic fibrosis transmembrane conductance regulator (CFTR) gene. Hum Genet. 1992 Jan;88(3):356–356. doi: 10.1007/BF00197276. [DOI] [PubMed] [Google Scholar]
  13. Schwarz M. J., Super M., Wallis C., Beighton P., Newton C., Heptinstall L. E., Summers C., Markham A., Hambleton G., Webb K. W. Delta F508 testing of the DNA bank of the Royal Manchester Children's Hospital. Hum Genet. 1990 Sep;85(4):428–430. doi: 10.1007/BF02428298. [DOI] [PubMed] [Google Scholar]
  14. Shoshani T., Augarten A., Gazit E., Bashan N., Yahav Y., Rivlin Y., Tal A., Seret H., Yaar L., Kerem E. Association of a nonsense mutation (W1282X), the most common mutation in the Ashkenazi Jewish cystic fibrosis patients in Israel, with presentation of severe disease. Am J Hum Genet. 1992 Jan;50(1):222–228. [PMC free article] [PubMed] [Google Scholar]
  15. Super M., Schwarz M. J., Malone G. Screening for cystic fibrosis carriers. Lancet. 1992 Aug 22;340(8817):490–491. doi: 10.1016/0140-6736(92)91816-q. [DOI] [PubMed] [Google Scholar]
  16. Super M., Schwarz M. J. Mutations of the cystic fibrosis gene locus within the population of the Northwest of England. Eur J Pediatr. 1992 Feb;151(2):108–111. doi: 10.1007/BF01958953. [DOI] [PubMed] [Google Scholar]
  17. Super M. The gene defect in cystic fibrosis and clinical applications of the knowledge. J R Soc Med. 1992;85 (Suppl 19):6–8. [PMC free article] [PubMed] [Google Scholar]
  18. Wald N. J., George L. M., Wald N. M., Mackenzie I. Couple screening for cystic fibrosis. Lancet. 1993 Nov 20;342(8882):1307–1308. doi: 10.1016/0140-6736(93)92403-g. [DOI] [PubMed] [Google Scholar]
  19. Watson E. K., Mayall E., Chapple J., Dalziel M., Harrington K., Williams C., Williamson R. Screening for carriers of cystic fibrosis through primary health care services. BMJ. 1991 Aug 31;303(6801):504–507. doi: 10.1136/bmj.303.6801.504. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Wilfond B. S., Fost N. The cystic fibrosis gene: medical and social implications for heterozygote detection. JAMA. 1990 May 23;263(20):2777–2783. [PubMed] [Google Scholar]

Articles from BMJ : British Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES